We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Call it unintended-but-predictable consequences: Launched this summer, a pharma industry campaign called "Let's Talk About Cost” highlights the role of insurers and middlemen in drug spending.